Efficacy of angiotensin-receptor blockers on demographic and clinico-pathological characteristics of breast cancer

Breast

Volumn 21, Issue 3, 2012, Pages 419-420

  Şendur, Mehmet A N ^a   Aksoy, Sercan ^a   Yaman, Sebnem ^a   Ozdemir, Nuriye Y ^a   Zengin, Nurullah ^a   Altundag, Kadri ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE FREE SURVIVAL; DRUG EFFICACY; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; LETTER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT DURATION;

EID: 84862586914     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2012.01.010     Document Type: Letter

References (5)

1. George A.J., Thomas W.G., Hannan R.D. The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer 2010, 10:745-759.
2. Ager E.I., Neo J., Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008, 29:1675-1684.
3. Sipahi I., Debanne S.M., Rowland D.Y., Simon D.I., Fang J.C. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol 2010, 11:627-636.
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
5. Herr D., Rodewald M., Fraser H.M., Hack G., Konrad R., Kreienberg R., et al. Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. Gynecol Oncol 2008, 109:418-425.